Bukwang Pharmaceutical (003000.KS) Dividend: History, Dates & Yield - 2024
Dividend History
Bukwang Pharmaceutical announced a annually dividend of ₩100.00 per ordinary share, payable on 2022-04-11, with an ex-dividend date of 2021-12-29. Bukwang Pharmaceutical typically pays dividends one times a year.
Find details on Bukwang Pharmaceutical's dividend performance with a comprehensive history of past and upcoming payments.
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2021-12-29 | ₩100.00 | annually | 2022-04-11 |
2020-12-29 | ₩90.91 | annually | 2021-04-09 |
2019-12-27 | ₩173.16 | annually | 2020-03-31 |
2018-12-27 | ₩133.20 | annually | 2019-03-29 |
2017-12-27 | ₩200.00 | annually | 2018-03-30 |
2016-12-28 | ₩600.00 | annually | |
2015-12-29 | ₩700.00 | annually | |
2014-12-29 | ₩500.00 | annually | |
2013-12-27 | ₩500.00 | annually | |
2012-12-27 | ₩430.00 | annually |
Dividend Increase
Bukwang Pharmaceutical's dividend growth over the last five years (2017-2021) was -21.51% per year, while over the last ten years (2012-2021), it was -10.50% per year and 000100.KS's growth rate was -13.64%.
By comparing Bukwang Pharmaceutical's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Bukwang Pharmaceutical's current trailing twelve-month (TTM) dividend yield is nan%. Over the last 12 months, Bukwang Pharmaceutical has maintained this yield, but how does it compare to similar stocks? For example, Daewoong pharmaceutical offers a yield of 0.45%, while 000100.KS provides a yield of 0.31%. Comparing similar stocks can help investors assess Bukwang Pharmaceutical's yield and make more informed decisions.
Company | Dividend Yield | Annual Dividend | Stock Price |
---|---|---|---|
Bukwang Pharmaceutical (003000.KS) | NaN% | ₩100 | ₩4900 |
Daewoong pharmaceutical (069620.KS) | 0.45% | ₩600 | ₩131400 |
000100.KS (000100.KS) | 0.31% | $428.57101 | $133100 |
Dividend Yield Calculator
Interested in purchasing Bukwang Pharmaceutical stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Bukwang Pharmaceutical has a payout ratio of 0.00%. In comparison, Daewoong pharmaceutical has a payout ratio of 0.01%, while 000100.KS's payout ratio is 0.18%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Bukwang Pharmaceutical
- Global presence Presence in multiple countries, serving various markets worldwide.
- Key Segments Offers products/services in a range of industries, including technology, healthcare, and consumer goods.
- Products/Services Diverse portfolio including software, medical devices, and household products.
- Financial stability Strong financial performance with consistent dividend payments and growth over time.
Frequently Asked Question
Other factors to consider when evaluating Bukwang Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bukwang Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bukwang Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bukwang Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bukwang Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bukwang Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bukwang Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bukwang Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bukwang Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bukwang Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bukwang Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.